Search
for
Sort by
Research 121–150 of 1000+
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Scalp Pustule as a Manifestation of Erlotinib-Induced Skin Toxicity: Report of Two Cases and Literature Review
- Cystatin M/E Variant Causes Autosomal Dominant Keratosis Follicularis Spinulosa Decalvans by Dysregulating Cathepsins L and V
- Ichthyosis
- <i>NIPAL4</i> deletion identified in an American Bully with autosomal recessive congenital ichthyosis and response to topical therapy
- Trichoscopy in Unveiling the Triad of Netherton Syndrome
- Recurrent pruritic polymorphic lesions associated with weight loss
- Phototherapy in Childhood
- Scalp Pruritus: Review of the Pathogenesis, Diagnosis, and Management
- Treatment of alopecia areata with squaric acid dibutylester
- Novel mutations of the ABCA12, KRT1 and ST14 genes in three unrelated newborns showing congenital ichthyosis
- Efficacy and safety of the Exfoliate-Dissolve-Repair skin care approach in the treatment of keratosis pilaris: a randomized controlled clinical trial study protocol
- Rare Coexistence of Monilethrix and Trichorrhexis Nodosa in a Pediatric Patient: A Case Report
- Extensive Spiculated Follicular Porokeratosis With Alopecia: A Case Report
- Culprits of Medication-Induced Telogen Effluvium, Part 1
- ESCITALOPRAM
- PLACK syndrome associated with alopecia areata and a novel homozygous base pair insertion in exon 18 of CAST gene
- Sorafenib-Associated Facial Acneiform Eruption
- Skin, Lung, Eyes, and Hair
- Mutations in ABCB6 Cause Dyschromatosis Universalis Hereditaria
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- The Cutaneous Epidermal Growth Factor Network: Can it be Translated Clinically to Stimulate Hair Growth?
- Persistent hair growth during treatment with the EGFR inhibitor erlotinib
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Expanding phenotype of hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis caused by FAM111B mutations: Report of an additional family raising the question of cancer predisposition and a short review of early-onset poikiloderma
- Skin manifestations associated with systemic diseases – Part I
- Cutaneous toxicities of new targeted cancer therapies: must know for diagnosis, management, and patient-proxy empowerment
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review